The Royal Melbourne Hospital
The Royal Melbourne Hospital
Melbourne, Victoria, Australia4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 1 | 2026-05-18 | NCT06324604 | |
| Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study | Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound Infection, Wound Infection | Recruiting | Phase 4 | 2026-03-25 | NCT05447559 | |
| A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 1 | 2025-09-11 | NCT06351904 | |
| BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, visual epilepsy | Active, not recruiting | Phase 1 / Phase 2 | 2022-08-30 | NCT03474770 |